Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital

About this trial

The purpose of this study is to explore if screening health-related social needs and early social work consultation is feasible and acceptable for adults with leukemias. The study examines whether the intervention (ACCESS-Leukemia) improves outcomes. Researchers will compare social determinants of health screening and early involvement of social work to usual care.

Eligibility criteria

Qualifiers

Acute myeloid leukemia (AML)

Acute lymphoblastic leukemia (ALL)

Intermediate or high-risk myelodysplastic syndrome (MDS), as defined by the revised International Prognostic Scoring System (IPSS-R) and/or IPSS-molecular (IPSS-M)

Intermediate or high-risk chronic myelomonocytic leukemia (CMML) by the CMML-specific prognostic scoring system (CPSS-Mol)

Disqualifiers

Adults unable to consent due to lack of capacity based on their leukemia clinician assessment.

Individuals who are not yet adults (infants, children, teenagers).

Trial design

Treatments tested in this trial

  • ACCESS-Leukemia

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Massachusetts General Hospital

Lead sponsor

Trefler Foundation

Collaborator